25 Results for "

pangenotypic

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "pangenotypic" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-12530
CAS No.: 1377049-84-7
Purity:  99.57%
Synonyms: GS-5816
Target:  

HCV SARS-CoV

Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111999A
CAS No.: 2242635-03-4
Purity:  99.48%
Target:  

STING

Research Areas:  

Cancer

E7766 diammonium salt is a macrocycle-bridged STING agonist with a Kd of 40 nM. E7766 diammonium salt shows potent pan-genotypic and antitumor activities .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137958
CAS No.: 2241337-84-6
Purity:  99.38%
Synonyms: AT-527
Target:  

HCV SARS-CoV

Research Areas:  

Infection

Bemnifosbuvir hemisulfate (AT-527), a hemisulfate salt of AT-511, a guanosine nucleotide proagent, is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir hemisulfate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 μM). Bemnifosbuvir hemisulfate has pangenotypic antiviral activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137958A
CAS No.: 1998705-64-8
Purity:  99.00%
Synonyms: AT-511
Target:  

HCV SARS-CoV

Research Areas:  

Infection

Bemnifosbuvir (AT-511) is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 μM). Bemnifosbuvir has pangenotypic antiviral activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101662
CAS No.: 1353900-92-1
Purity:  99.94%
Synonyms: ABT-530
Target:  

HCV

Research Areas:  

Infection

Pibrentasvir is a novel and pan-genotypic hepatitis C virus (HCV) NS5A inhibitor with EC50s ranging from 1.4 to 5.0 pM against HCV replicons containing NS5A from genotypes 1 to 6.
loading...
    loading...
Cat. No.: HY-19840
CAS No.: 1535212-07-7
Synonyms: GS-9857
Target:  

HCV Protease

Research Areas:  

Infection Cancer

Voxilaprevir (GS-9857) is a noncovalent, reversible inhibitor of HCV NS3/4A protease inhibitor (PI) with pangenotypic antiviral activity . Voxilaprevir inhibits genotype 1b and 3a wild-type NS3 proteases with Ki values of 0.038 nM and 0.066 nM, respectively . Voxilaprevir is an orally active direct-acting antiviral agent (DAA) and can be used for HCV infection research .
loading...
    loading...
Cat. No.: HY-124191
CAS No.: 1303533-81-4
Purity:  99.94%
Synonyms: PPI-668 hydrochloride
Target:  

HCV

Research Areas:  

Infection

Ravidasvir hydrochloride (PPI-668 hydrochloride) is a pan-genotypic inhibitor for hepatitis C virus (HCV) NS5A protein. Ravidasvir hydrochloride inhibits the replication of HCV, with EC50 of 0.12, 0.01 and 1.14 nM, for HCV gt-1a, gt-1b, and gt-3a replicons, respectively. Ravidasvir hydrochloride exhibits good pharmacokinetic characters in rats .
loading...
    loading...
Cat. No.: HY-117411A
CAS No.: 1966138-53-3
Purity:  99.19%
Synonyms: KW-136 dihydrochloride
Target:  

HCV HCV Protease

Research Areas:  

Infection

Coblopasvir (KW-136) dihydrochloride is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir dihydrochloride can be used for research of chronic hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-12530R
CAS No.: 1377049-84-7
Synonyms: GS-5816 (Standard)
Velpatasvir (Standard) is the analytical standard of Velpatasvir. This product is intended for research and analytical applications. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-111999B
CAS No.: 2242636-28-6
Target:  

STING

Research Areas:  

Cancer

E7766 disodium is a macrocycle-bridged STING agonist with a Kd of 40 nM. E7766 disodium shows potent pan-genotypic and antitumor activities .
loading...
    loading...
Cat. No.: HY-117411
CAS No.: 1312608-46-0
Synonyms: KW-136
Target:  

HCV HCV Protease

Research Areas:  

Infection Inflammation/Immunology

Coblopasvir (KW-136) is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir can be used for research of chronic hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-12530S1
Synonyms: GS-5816-d33
Velpatasvir-d3 (GS-5816-d3) is deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-133018
CAS No.: 1449756-86-8
Target:  

HCV

Research Areas:  

Infection

HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor with IC50s of 3-47 pM. HCV-IN-7 shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. HCV-IN-7 has anti-viral activity .
loading...
    loading...
Cat. No.: HY-133018A
CAS No.: 1449756-87-9
Target:  

HCV

Research Areas:  

Cancer

HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor with IC50s of 3-47 pM. HCV-IN-7 hydrochloride shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. HCV-IN-7 hydrochloride has anti-viral activity .
loading...
    loading...
Cat. No.: HY-117967
CAS No.: 1620479-63-1
Target:  

HCV Protease

Research Areas:  

Infection

MK-6169 is a potent, pan-genotypic hepatitis C virus NS5A inhibitor .
loading...
    loading...
Cat. No.: HY-124592
CAS No.: 1628720-84-2
BMT-052 is a pan-genotypic hepatitis C (HCV) NS5B polymerase primer grip inhibitor .
loading...
    loading...
Cat. No.: HY-W749691
Synonyms: (S)-GS-5816-13C,d3
(S)-Velpatasvir- 13C,d3 ((S)-GS-5816- 13C,d3) is 13C labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-12530S3
Synonyms: GS-5816-13C,d3
Velpatasvir- 13C,d3 (GS-5816- 13C,d3) is 13C and deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-146126
CAS No.: 2088243-03-0
Target:  

HCV Protease

Research Areas:  

Infection

NS5A-IN-4 (Compound 1.12) is an orally active pan-genotypic hepatitis C virus (HCV) NS5A inhibitor with IC50 values of 1.2, 2296, 4.6, 362, 10.3 and 693 pM against gT1b, gT1a, gT2a, gT3a, gT4a and gT5a . NS5A-IN-4 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-117620
CAS No.: 1374883-22-3
Target:  

HCV

Research Areas:  

Infection

TD-6450 (Compound 51) is an orally active HCV 1A inhibitor. TD-6450 inhibits the pan-genotypic nonstructural protein 5A (NS5A). TD-6450 can be used for research on diseases such as hepatitis .
loading...
    loading...